These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 33771989)

  • 21. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.
    Sielska M; Przanowski P; Wylot B; Gabrusiewicz K; Maleszewska M; Kijewska M; Zawadzka M; Kucharska J; Vinnakota K; Kettenmann H; Kotulska K; Grajkowska W; Kaminska B
    J Pathol; 2013 Jul; 230(3):310-21. PubMed ID: 23520016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.
    Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of host-derived osteopontin creates a glioblastoma-promoting microenvironment.
    Szulzewsky F; Schwendinger N; Güneykaya D; Cimino PJ; Hambardzumyan D; Synowitz M; Holland EC; Kettenmann H
    Neuro Oncol; 2018 Feb; 20(3):355-366. PubMed ID: 29016864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of tumor progression and M2 microglial polarization by extracellular vesicle-mediated microRNA-124 in a 3D microfluidic glioblastoma microenvironment.
    Hong S; You JY; Paek K; Park J; Kang SJ; Han EH; Choi N; Chung S; Rhee WJ; Kim JA
    Theranostics; 2021; 11(19):9687-9704. PubMed ID: 34646393
    [No Abstract]   [Full Text] [Related]  

  • 25. Down-regulation of IKKβ expression in glioma-infiltrating microglia/macrophages is associated with defective inflammatory/immune gene responses in glioblastoma.
    Mieczkowski J; Kocyk M; Nauman P; Gabrusiewicz K; Sielska M; Przanowski P; Maleszewska M; Rajan WD; Pszczolkowska D; Tykocki T; Grajkowska W; Kotulska K; Roszkowski M; Kostkiewicz B; Kaminska B
    Oncotarget; 2015 Oct; 6(32):33077-90. PubMed ID: 26427514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TLR4 expression and functionality are downregulated in glioblastoma cells and in tumor-associated macrophages: A new mechanism of immune evasion?
    da Cruz LLP; de Souza PO; Dal Prá M; Falchetti M; de Abreu AM; Azambuja JH; Bertoni APS; Paz AHR; Araújo AB; Visioli F; Fazolo T; da Silva GG; Worm PV; Wink MR; Zanotto-Filho A; Braganhol E
    Biochim Biophys Acta Mol Basis Dis; 2021 Aug; 1867(8):166155. PubMed ID: 33932524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of CD73 delays glioblastoma growth by modulating the immune environment.
    Azambuja JH; Schuh RS; Michels LR; Iser IC; Beckenkamp LR; Roliano GG; Lenz GS; Scholl JN; Sévigny J; Wink MR; Stefani MA; Battastini AMO; Figueiró F; Teixeira HF; Braganhol E
    Cancer Immunol Immunother; 2020 Sep; 69(9):1801-1812. PubMed ID: 32350590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HYBID derived from tumor cells and tumor-associated macrophages contribute to the glioblastoma growth.
    Tsuji S; Nakamura S; Yamada T; de Vega S; Okada Y; Inoue S; Shimazawa M; Hara H
    Brain Res; 2021 Aug; 1764():147490. PubMed ID: 33887254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CXCL16/CXCR6 Axis Drives Microglia/Macrophages Phenotype in Physiological Conditions and Plays a Crucial Role in Glioma.
    Lepore F; D'Alessandro G; Antonangeli F; Santoro A; Esposito V; Limatola C; Trettel F
    Front Immunol; 2018; 9():2750. PubMed ID: 30542347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-associated hematopoietic stem and progenitor cells positively linked to glioblastoma progression.
    Lu IN; Dobersalske C; Rauschenbach L; Teuber-Hanselmann S; Steinbach A; Ullrich V; Prasad S; Blau T; Kebir S; Siveke JT; Becker JC; Sure U; Glas M; Scheffler B; Cima I
    Nat Commun; 2021 Jun; 12(1):3895. PubMed ID: 34162860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VEGF as a modulator of the innate immune response in glioblastoma.
    Turkowski K; Brandenburg S; Mueller A; Kremenetskaia I; Bungert AD; Blank A; Felsenstein M; Vajkoczy P
    Glia; 2018 Jan; 66(1):161-174. PubMed ID: 28948650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revealing and Harnessing Tumour-Associated Microglia/Macrophage Heterogeneity in Glioblastoma.
    Pires-Afonso Y; Niclou SP; Michelucci A
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973030
    [No Abstract]   [Full Text] [Related]  

  • 33. Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma.
    Bougnaud S; Golebiewska A; Oudin A; Keunen O; Harter PN; Mäder L; Azuaje F; Fritah S; Stieber D; Kaoma T; Vallar L; Brons NH; Daubon T; Miletic H; Sundstrøm T; Herold-Mende C; Mittelbronn M; Bjerkvig R; Niclou SP
    Oncotarget; 2016 May; 7(22):31955-71. PubMed ID: 27049916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages.
    Yin J; Kim SS; Choi E; Oh YT; Lin W; Kim TH; Sa JK; Hong JH; Park SH; Kwon HJ; Jin X; You Y; Kim JH; Kim H; Son J; Lee J; Nam DH; Choi KS; Shi B; Gwak HS; Yoo H; Iavarone A; Kim JH; Park JB
    Nat Commun; 2020 Jun; 11(1):2978. PubMed ID: 32532977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumour-associated CD204
    Sørensen MD; Kristensen BW
    Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12772. PubMed ID: 34713474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The metastatic microenvironment: Melanoma-microglia cross-talk promotes the malignant phenotype of melanoma cells.
    Izraely S; Ben-Menachem S; Sagi-Assif O; Telerman A; Zubrilov I; Ashkenazi O; Meshel T; Maman S; Orozco JIJ; Salomon MP; Marzese DM; Pasmanik-Chor M; Pikarski E; Ehrlich M; Hoon DSB; Witz IP
    Int J Cancer; 2019 Feb; 144(4):802-817. PubMed ID: 29992556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling.
    Coniglio SJ; Eugenin E; Dobrenis K; Stanley ER; West BL; Symons MH; Segall JE
    Mol Med; 2012 May; 18(1):519-27. PubMed ID: 22294205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploiting Microglial Functions for the Treatment of Glioblastoma.
    Dello Russo C; Lisi L; Tentori L; Navarra P; Graziani G; Combs CK
    Curr Cancer Drug Targets; 2017; 17(3):267-281. PubMed ID: 27528361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD73 Promotes Glioblastoma Pathogenesis and Enhances Its Chemoresistance via A
    Yan A; Joachims ML; Thompson LF; Miller AD; Canoll PD; Bynoe MS
    J Neurosci; 2019 May; 39(22):4387-4402. PubMed ID: 30926752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FTY720 Exerts Anti-Glioma Effects by Regulating the Glioma Microenvironment Through Increased CXCR4 Internalization by Glioma-Associated Microglia.
    Guo XD; Ji J; Xue TF; Sun YQ; Guo RB; Cheng H; Sun XL
    Front Immunol; 2020; 11():178. PubMed ID: 32194542
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.